Parse Biosciences - Scalable Single Cell Sequencing
On-Demand Webinar

Using Single Cell RNA Sequencing (scRNA-Seq) to Examine What Makes Cancer Possible


Tumors originate due to mutations in oncogene/tumor suppressor genes in which abnormal activity or inactivity transforms cells from normal to tumor. However, oncogne-driver mutations do not fully explain the emergence of tumors.

In this webinar, Dr. Katerina Gurova, Roswell Park Cancer Institute, describes how she used scRNA-Seq to examine whether the transition between one epigenetic state into another makes cells vulnerable to oncogene induced transformation.

What you'll learn:

  • More about the Gurova Lab and how they are identifying new ways to get ahead of cancer.
  • How single cell RNA sequencing (scRNA-seq) can be used to identify what makes cells vulnerable to oncogene induced transformation.
  • More about the Evercode split-pool combinatorial barcoding platform from Parse Biosciences.